User profiles for Lluís Puig
Lluis PuigHead, Department of Dermatology, Hospital de la Santa Creu i Sant Pau Verified email at santpau.cat Cited by 28323 |
[HTML][HTML] La prevalencia de diez enfermedades inflamatorias inmunomediadas (IMID) en España
Fundamentos: Las enfermedades inflamatorias inmunomediadas (IMID) son enfermedades
crónicas y altamente discapacitantes que comparten secuencias inflamatorias y …
crónicas y altamente discapacitantes que comparten secuencias inflamatorias y …
[HTML][HTML] Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies
Interleukin 17 (IL-17) is a proinflammatory cytokine that has been the focus of intensive
research because of its crucial role in the pathogenesis of different diseases across many …
research because of its crucial role in the pathogenesis of different diseases across many …
[PDF][PDF] Pointed groups and construction of modules
L Puig - Journal of Algebra, 1988 - core.ac.uk
… Puig’s pointed groups correspond one-to-one to the [isomorphism classes of] indecomposable
AH-direct summands of A where H runs over all the subgroups of G. It follows that all his …
AH-direct summands of A where H runs over all the subgroups of G. It follows that all his …
[HTML][HTML] Secukinumab in plaque psoriasis—results of two phase 3 trials
Background Interleukin-17A is considered to be central to the pathogenesis of psoriasis. We
evaluated secukinumab, a fully human anti–interleukin-17A monoclonal antibody, in …
evaluated secukinumab, a fully human anti–interleukin-17A monoclonal antibody, in …
Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial
IB McInnes, A Kavanaugh, AB Gottlieb, L Puig… - The Lancet, 2013 - thelancet.com
Background Many patients with psoriasis develop psoriatic arthritis, a chronic inflammatory
disease that afflicts peripheral synovial, axial, and entheseal structures. The fully human …
disease that afflicts peripheral synovial, axial, and entheseal structures. The fully human …
Inflammatory, immune-mediated adverse reactions related to soft tissue dermal fillers
…, MT Fernández-Figueras, L Puig - Seminars in arthritis and …, 2013 - Elsevier
Background An increasing number of persons seek medical solutions for esthetic indications
and for diverse pathological conditions, such as malformations, trauma, or cancer. Despite …
and for diverse pathological conditions, such as malformations, trauma, or cancer. Despite …
[HTML][HTML] Cardiometabolic comorbidities in psoriasis and psoriatic arthritis
L Puig - International journal of molecular sciences, 2017 - mdpi.com
There is solid epidemiologic evidence linking psoriasis and psoriatic arthritis (PsA) to
cardiovascular risk factors and an increased risk of developing cardiovascular disease. Chronic …
cardiovascular risk factors and an increased risk of developing cardiovascular disease. Chronic …
Psoriasis y su relación con el síndrome metabólico
… Lluís Puig ha recibido honorarios en concepto de asesorías y/o conferencias de Abbvie,
Boehringer, Janssen, Merck-Serono, MSD, Novartis y Pfizer. Ha participado en ensayos …
Boehringer, Janssen, Merck-Serono, MSD, Novartis y Pfizer. Ha participado en ensayos …
Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled …
Background Risankizumab is a humanised IgG1 monoclonal antibody that binds to the p19
subunit of interleukin-23, inhibiting this key cytokine and its role in psoriatic inflammation. We …
subunit of interleukin-23, inhibiting this key cytokine and its role in psoriatic inflammation. We …
Patient perspectives in the management of psoriasis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey
Background Available psoriasis surveys offer valuable information about psoriasis and psoriatic
arthritis (PsA), but are limited by methodology or enrollment requirements. Objective To …
arthritis (PsA), but are limited by methodology or enrollment requirements. Objective To …